Related Experiment Video
Updated: May 12, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
LABAs in asthmatic children: highlights and new inside
M Miraglia del Giudice1, M G Matera, C Capristo
1Department of Pediatrics, Second University of Naples, Naples, Italy. michele.miraglia@unina2.it
Pulmonary Pharmacology & Therapeutics
|April 16, 2013
Summary
For uncontrolled asthma in children on low-dose inhaled corticosteroids (ICS), adding long-acting inhaled beta2-agonists (LABAs) is recommended but lacks clear efficacy and safety data in pediatric populations.
Area of Science:
- Pediatric Pulmonology
- Asthma Management
- Pharmacology
Background:
- International guidelines suggest increasing inhaled corticosteroid (ICS) dosage or adding leukotriene modifiers for uncontrolled asthma.
- Combination therapy with ICS and long-acting inhaled beta2-agonists (LABAs) is a recommended option for adults and children with persistent asthma.
Purpose of the Study:
- To evaluate the efficacy and safety of adding LABAs to ICS in pediatric asthma patients.
- To address the lack of comprehensive studies on LABA use in children.
- To explore potential implications of new findings on airway remodeling for future asthma management.
Main Methods:
- Review of existing studies on ICS/LABA combination therapy in pediatric asthma.
- Analysis of age restrictions for specific LABAs (salmeterol >4 years, formoterol >6 years).
- Consideration of recent research on bronchoconstriction-induced epithelial cell stress and airway remodeling.
Main Results:
- Limited studies exist on the efficacy and safety of LABA/ICS combination therapy in children.
- Specific age restrictions apply to commonly used LABAs in pediatric populations.
- Emerging evidence links repeated bronchoconstriction to epithelial cell stress and potential airway remodeling.
Conclusions:
- The use of LABAs in combination with ICS for pediatric asthma requires further investigation due to limited pediatric-specific data.
- Future asthma management strategies may need to consider the impact of treatments on airway remodeling.
- Current age restrictions for LABAs in children necessitate careful consideration during treatment selection.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: